μ-Chlorido-bis-{[1-benzyl-3-(2,4,6-tri-methyl-phen-yl)imidazol-2-yl-idene-κC]silver(I)} chloride 1,2-di-chloro-ethane hemisolvate.

The title compound, [Ag(2)(C(19)H(20)N(2))(4)]Cl·0.5C(2)H(4)Cl(2), can be readily generated by treatment of (1-benzyl-3-(2,4,6-tri-methyl-phen-yl)imidazolium chloride with sodium bis-(tri-methyl-sil-yl)amide followed by silver chloride. The mol-ecular structure of the compound was confirmed using NMR spectroscopy and single-crystal X-ray diffraction analysis. The crystal structure of the title compound at 110†K has monoclinic (P2(1)/c) symmetry. The represented silver compound is of inter-est with respect to anti-bacterial properties and the structure displays a series of weak inter-molecular hydrogen-bonding inter-actions with the chloride counter-anion.